NA Proactive news snapshot: PyroGenesis Canada, CytoDyn, Los Andes Copper, Nextleaf, Todos Medical ...

PyroGenesis Canada Inc (TSE:PYR) (NASDAQ:PYR) (FRA:8PY) announced strong year-end results on Wednesday evening that saw the company deliver nearly $42 million in earnings during the year. The technology company’s 2020 revenue came in at $17.8 million, a 269% increase over the $4.8 million it put up in 2019. What’s more, the Montreal-based firm swung to a profit, posting net earnings of $41.8 million or $0.28 per share compared to the $9.2 million loss or $0.07 per share in FY2019.

CytoDyn Inc (OTCQB:CYDY), a biotechnology company developing its flagship drug Vyrologix (leronlimab-PRO 140) for multiple indications, revealed Thursday that after several weeks of discussions with the US Food and Drug Administration (FDA), and analysis of CD12 trial data, it has filed a new protocol to extend treatment to four weeks. This decision comes after Vancouver-based CytoDyn shared positive data on Tuesday from its CD12 trial of leronlimab in severe-to-critical coronavirus (COVID-19), revealing that the drug decreases mortality by 82% after two weeks of treatment among critical patients. 

Los Andes Copper Ltd (CVE:LA) (OTCMKTS:LSANF) (FRA:L41A) has welcomed the final results of metallurgical testing on ore from its Vizcachitas porphyry project in Chile, which confirmed that a future mine could produce “clean and high-quality” copper concentrate. The work was part of the ongoing pre-feasibility study (PFS) for the asset, which is set to become the South American country’s next copper mine, and showed copper recovery of 91.4% and that a high-quality clean copper concentrate at 24.5% could be generated.  

Nextleaf Solutions Ltd (CSE:OILS) (OTCQB:OILFF) (FRA:L0MA) has closed a private placing with an institutional investor, raising C$3 million gross, which it says will be used to enhance the company’s automation and additional manufacturing capabilities in 2021. The financing is in the form of a senior secured convertible note of the company in the principal amount of C$3.3 million and a warrant to purchase up to 6.875 million Nextleaf shares.

Todos Medical Ltd (OTCQB:TOMDF) announced Thursday the successful installation of automated lab equipment and the completion of training for New Jersey-based lab client Meadowlands Diagnostics. The solution is expected to be instrumental in helping Meadowlands Diagnostics with new contracts entered into with skilled nursing facilities, ambulatory surgery centers, local schools, and first responders. As the provider of PCR testing supplies to Meadowlands Diagnostics, Todos added that it expects to see a progressive increase in sales to this client in the second half of 2021 and into 2022 as the lab seeks to grow its PCR testing business. By implementing the automation solution, Todos said Meadowlands Diagnostics now has a capacity of 6,000 PCR tests per day, with the potential to quickly expand to up to 12,000 PCR tests per day. 

Trillion Energy International Inc. (CSE:TCF) (OTCMKTS:TCFF) (FRA:3P2N), which is building an integrated oil and gas portfolio along the Black Sea, revealed that it has settled a total of $749,771.20 in outstanding debt through the issuance to certain creditors of 1,874,428 common shares at a deemed issue price of $0.40 per common share. The securities issued in connection with the debt settlement will be subject to a four-month hold period in accordance with applicable securities laws. The Canadian natural gas and oil producer is focused on international markets with several oil and gas assets in Turkey and Bulgaria. It is a 49% owner of the SASB natural gas field, one of the Black Sea’s first and largest natural gas development projects.

Codebase Ventures Inc (CSE:CODE) (FRA:C5B) (OTCQB:BKLLF) on Thursday provided an update on the continued development of its proposed transdermal delivery technology for hydroxychloroquine (HCQ). The company said it had engaged TRPL (Transdermal Research Pharm Laboratories) of Long Island City, New York, to conduct a feasibility study — which indicates that HCQ has all the required parameters to be a transdermal candidate. Moreover, in recognition of the potential value of this legacy asset and in light of the company’s current focus on the blockchain and related emerging technology ecosystem, Codebase said it is investigating spinning out its interest in the transdermal delivery technology for HCQ. Codebase said details on any such spin-out will be provided in the coming weeks as it explores deal structures with its partners to ensure its shareholders benefit.

CytoDyn Inc (OTCQB:CYDY), a biotechnology company developing its flagship drug Vyrologix (leronlimab-PRO 140) for multiple indications, said CEO Nader Pourhassan, Chairman Scott Kelly, COO Christopher Recknor, and Mahboob Rahman, the Chief Scientific Officer, will host an investment community webcast on Tuesday, April 6, 2021. Management will provide a full update to its stockholders on company activities, including recent COVID-19 initiatives and information concerning its active trials in COVID-19, NASH and cancer. Management will provide approximately 60 minutes to address questions submitted online by analysts and investors. Prior to the webcast, questions can be submitted online to [email protected]

Biocept Inc (NASDAQ:BIOC) (FRA:B003) will host a webinar featuring leading neuro-oncologists to discuss the use of its proprietary cerebrospinal fluid (CSF) assay for diagnosing and managing tumors that have metastasized to the central nervous system (CNS), including the brain or spinal column. The company said its CSF assay provides enhanced sensitivity compared with CSF cytology, the current standard-of-care, and has the added advantage of identifying actionable molecular targets for use in treatment decisions while providing quantitative information needed for assessing treatment response and monitoring disease progression. The webinar will be held on April 8 at 12 pm ET.

KushCo Holdings Inc (OTCQX:KSHB) said it is scheduled to host a conference call and webcast on Thursday, April 8, 2021 at 4:30 pm ET to discuss its financial and operational results for the fiscal second quarter to February 28, 2021.  The results will be announced after market close on April 8. Details are: Toll-free Number: 1-877-407-9124; International Number: 1-201-689-8584; Webcast Link: Here

Pacton Gold Inc (CVE:PAC) (OTCPINK:PACXF) (FRA:2NKM)  said the TSX Venture Exchange has accepted for filing the company’s proposal to issue 100,000 common shares in consideration of a finder’s fee owed to Cobra Investments (Aust) Pty. Ltd. in connection with the disposition of the company’s 75% interest in three Western Pilbara gold properties to Raiden Resources Ltd.

GlobeX Data Ltd (OTCQB:SWISF) (CSE:SWIS) (FRA:GDT) reported that it has completed its previously-announced C$1.2 million non-brokered private placement equity financing, after issuing 4,076,400 units of the company at a price of C$0.30 per unit. The company said the proceeds will be used primarily for operational sales and the marketing of its Sekur security solution, offering secure email, instant messaging and file sharing, as well as any other marketing-related activity for sales in Canada, the US, Latin America and South Asia. 

Steppe Gold Limited (TSE:STGO) (OTCQX:STPGF) announced the filing of a technical report on its 100% owned Altan Tsagaan Ovoo (ATO) Project in Mongolia for the updated mineral resource estimate announced on February 24, 2021. The report is available under the company’s profile on SEDAR at www.sedar.com and on the company’s website at www.steppegold.com.
 

Story by ProactiveInvestors